Biotechnology Program - Health Sciences Talk about cool - have you ever seen a rose CLONED? Learn more about the Biotechnology Degree Program here: bit.ly The Bachelor of Science in Biotechnology, Honours (Co-op) is a joint initiative of the University of British Columbia department of Microbiology and Immunology and the BCIT Biotechnology program. This unique Bachelor of Science program combines the extensive training in science theory available at UBC with the extensive laboratory training available in the BCIT Biotechnology program. The joint program is intended to produce students with strong scientific and technical backgrounds and who are also well schooled in business and communications. As a new initiative, this unique Joint Degree program underwent extensive scrutiny to ensure that it met the technical and academic requirements mandated by both institutions. To ensure the excellence of the program, it is annually reviewed by a Program Advisory Committee. The program addresses the documented need for people who can combine technical experience and training with expertise in other areas such as management, production, regulations and intellectual property. It provides a core set of skills required for all levels of employment in a typical biotechnology company. Our Biotechnology students in the School of Health Sciences at BCIT have a thing or two to show us! Check it out! Where do UBC science students go after University? BCIT
Biotech Fashion Show Biotechnology is everywhere. From food to fuel to fashion. Watch the fashion show to see clothes that were made with biotechnology.
Made in Germany | Qiagen -- Biotech Buy-Up
the power of biotechnology!! biotechnology is the most upcoming filed in science and technology!!! it has the power of doing what only god can do...
Sector to Watch: Biotech Record for Biotechs as Stocks Become Takeover Targets; Small Cap Biotechs Might Be Better Bet
Financing Canadian Biotech - Flow Through Shares BIOTECanada President and CEO, Peter Brenders was interviewed on CBC's The Lang & O'Leary Exchange on the state of the biotech industry in Canada and to discuss PricewaterhourseCoopers recent Life Sciences Industry Forecast 2011.
Biotech Is Godzilla This song was performed by Sepultura and mentions Godzilla in the song.
Algae Biofuels and Biotech - Stephen Mayfield UC San Diego Algae expert Stephen Mayfield discusses latest research in algae biotechnology for fuel and pharmaceuticals. Series: On Beyond [Science] [Show ID: 18007]
Argentina's polo ponies race ahead, with biotech help Scientists and breeders in Argentina may just have come up with the ideal polo horse. Bred from the Criollo horse, renowned for its endurance, and the agile Thoroughbred of the race track, the "Polo Argentino" has taken off over the past few years, and so have its sales abroad, with exports quadrupling in the past two years alone.Duration: 02:04
The Biotechnology Age This video was featured on the "Video Wall" at the 2008 BIO International Convention in San Diego.
Biotechnology in the Labratory If you really want to understand biotechnology, just visit a laboratory. There you will meet some of the most brilliant and dedicated scientists in the world. Coming up with new cures for diseases and discovering new renewable fuels and helping to make the world's farmers more productive. And what they do is astonishing! It all starts with a cell -- the basis of life -- the foundation of Biotechnology...
BioByte 101 - What is biotechnology? This video provides a basic overview of biotechnology and its many applications in our daily lives.
Biotech Rap- Transformation Feat. Notorious GFP The freshest joint from the most ***, yet science related, crew in Toronto: Biotech Nation. Fresh outta murder high sayyyy whattt Lyrics: yo, this is for my boy he was living the hip hop dream and then he got shot nine times in the face, with a gene gun yo jamal mallindrome, this for you yea, check it check it, one take, a-town, say what chorus: transforming dna is a process not to hard, dna can always be changed, it happens everyday transforming dna is a process not to hard, dna will make my day in every single way (yo, yo) 1 2 3 biotechnology, I got me a-tam, jack huang, jimmy lee, be up in mrs gauci's class popping the pill, before I was sick, but now im just plain ill (yo,yo) yo it was oh-five when i was last up on this game, nows its oh-six and i'm trying to make myself a name and the cell membrane is all mosaic and fluid, now this is the point where the trouble starts brewing, so i put it on ice, like the grills on my teeth it gets rigid and hard like the life on the streets (true dat) Plasma ain't got rhythm he aint got no flow, cant get into the cell unless you open the door, (yes yes) so just to let you know, i got my mind on the chedder, need to increase competance, the cheaper the better chorus got use the heat shock to help with the flow, you aint got any heat, you aint got any show. the draft created by the 42 degrees, makes the DNA flow through the membrane with ease. The punishment you dealt shouldn't have been a crime, so cut the slack fool, with some ...
Biotechnology at the Cutting Edge Get an introduction to some of today's top researchers and the basics of biotechnology biofuel, genetics, health, and agriculture. This video features interviews with four leading scientists in biotechnology who tell us what drew them to the field: Dr. Pardis Sabeti, Assistant Professor of Organismic and Evolutionary Biology, Harvard University Dr. Jay Keasling, Chief Executive Officer, Joint BioEnergy Institute, US Department of Energy Dr. Karen Nelson, Director, Rockville, Maryland, Campus of the J. Craig Venter Institute Dr. Robert Fraley, Executive Vice President and Chief Technology Officer, Monsanto Company Note: A version of this video is available in the "Science in American Life" exhibition at the National Museum of American History. americanhistory.si.edu
Great Biotech Ideas * Rodman & Renshaw Annual Global Investment Conference * Oxigene discuss Zybrestat which is in Phase III * GTX discuss Fareston and Toremifene
Biotech Stocks on the Move * Merriman Curhan Ford 5th Annual Investor Summit * Curis cancer drug in clinical trials * GenVec cancer drug enters Phase III * MediciNova discusses early test for asthma and MS drugs
Kiwa biotech Kiwa profiled on Phoenix network
Nucleus Biotechnology Animation Demo Reel Nucleus Medical Media's biotechnology demo reel shows examples of molecular biology, mechanism of action (MOA) and physiology at the cellular and subcellular level.
Hate Brussels Sprouts? It's Genetic - Pearl Biotech's Open PCR Project If you hate the taste of Brussels sprouts it's likely genetic and now you can prove it to your mom and dad with the Pro Biotech's open source PCR project. Gene sequencing at home. Filmed at Maker Faire California 2010
Biotech Revolution 1 of 6 For a full playlist of all chapters, please click on: Genetics and Biotechnology promise a future of unprecedented health and longevity: DNA screening could prevent many diseases, gene therapy could cure them and, thanks to lab-grown organs, the human body could be repaired as easily as a car, with spare parts readily available. Ultimately, the ageing process itself could be slowed down or even halted. Leading theoretical physicist and futurist Michio Kaku looks at the revolution in genetics and biotechnology, which promises unprecedented health and longevity but also raises the spectre of a Frankenstein future of genetically engineered people. Will we, as transhumanists expect, evolve into a new species? Dr Kaku warns that we may end up in a world divided by genetic apartheid. Visions of the Future: Episode 1: The Intelligence Revolution Theoretical physicist and futurist Michio Kaku shows how, in the 21st century, artificial intelligence is going to become as ubiquitous as electricity, how robots with human-level intelligence may finally become a reality, and how we'll even be able to merge our minds with machine intelligence. As the challenges and choices are literally mind-bending, Dr Kaku asks how far we will ultimately go. Episode 2: The Biotech Revolution Leading theoretical physicist and futurist Michio Kaku looks at the revolution in genetics and biotechnology, which promises unprecedented health and ...
In-Depth Look - Biotechnology Industry Outlook - Bloomberg An interview with Drew Fromkin, the CEO of Clinical Data with his outlook on Biotechnology industry and of Clinical Data. (Bloomberg News)
Biotech 2009 - Navigating the Sea Change, published by Burrill Media Biotech 2009-Life Sciences: Navigating the Sea Change is the 23rd edition of this yearly publication. It provides a compass to guide you through the current financial market turmoil. The 400-plus page book contains ***ysis and perspectives on the performance of the industry in 2008 and projections for 2009 and beyond. The biotech industry has had nearly 40 years of easy access to inexpensive capital. The capital markets have permanently restructured, making access to capital more difficult and expensive to access. The changes mean: - Buy-side interest and resources are reduced. - Venture capitalist and private investors no longer can rely on IPOs for exits. - Big Pharma is not as eager to make deals. As these companies see it, technology will be cheaper to buy if they wait. - Falling oil prices may slow the momentum for alternate fuels. About Burrill Media Burrill Media is the creator, sponsor and facilitator of over a dozen leading industry conferences worldwide and publishes a wide range of bio-intelligence reports. Annual conferences include The Biotech Meeting, The Indiana Life Sciences Forum, The Burrill Personalized Medicine Meeting, The Aging Meeting and The Stem Cell Meeting. Burrill Media publications include the annual State of the Industry, The Personalized Medicine Report, The Stem Cell Report, and periodic newsletters covering Canada, China, Europe, India, Japan and Partnering/M&A. Burrill also publishes The Burrill Report, a bimonthly magazine.OneMedTV is ...
Biotechnology: The Invisible Revolution
Dr.Hoeffler's Adv Biotech 3.22.11pt2.MTS
Shortfilm about the BIO-Europe 2008 in the Biotech-Cluster Rhein-Neckar (BioRN) Mannheim, Germany, November 17th 2008 - At the opening of the BIO-Europe 2008 Partnering Conference, Roche, Merck Serono and Abbott announced today to join forces in the development of the Biotechnology Cluster Rhine-Neckar (BioRN) towards a leading position in the field of medical biotechnology in Europe. The BioRN cluster was recently awarded a 40 million euro federal grant by the German Ministry for Education and Research as one of the top five high-tech clusters in Germany. In addition, BioRN is the host of this years BIO-Europe, which has established itself as the worlds largest stand-alone partnering conference. "The success of the BioRN cluster, which brings together some 100 partners in business and research, rests partly on the excellent pioneering research being done here in the Rhine-Neckar region and on the presence of several major corporations, many of them global leaders in their field such as Roche, Merck Serono and Abbott," said Dr. Jürgen Schwiezer, Chief Executive Officer of the Roche Diagnostics Division. "We are proud to contribute to a number of promising collaborations within this cluster," added Dr. Bernhard Kirschbaum, Executive Vice President, Research and Development, at Merck Serono. "The strong network that is now formed in the Rhine-Neckar region will lead to the faster translation of technological advances and market intelligence into competitive advantage and ultimately benefits for patients." Roche and Merck Serono, together with major ...
Biotechnology Brazil: Green fuel from GM crops FW journalist Ian Ashbridge discovers how Brazilian scientists want to use GM technology in sugar cane to make bioethanol production more efficient.
World Business: Barcelona Biotech 15/05/09 World Business: The Spanish economy seems to be suffering more than most in this economic down turn, it has the highest unemployment rate in Europe. But it is seeing positive growth in one or two sectors, including biotechnology. The city of Barcelona is emerging as the centre of this new growth area. Reporter: Joanna Harrison
BioBytes: Biotechnology and Plant Made Pharmaceuticals When you look at a field of tobacco plants, your first thought probably isn't about its medicinal uses. But in a few years, this crop may help produce life-saving vaccines and therapies for diseases such as cancer, diabetes, Cystic Fibrosis, and arthritis - just to name a few. Biotechnology researchers are currently exploring the production of plant made pharmaceuticals - which basically means using plants to produce protein-based pharmaceuticals. Dr. Targan explains how the process works, and how this type of research could make pharmaceutical manufacturing more affordable in the future.
Biotechnology & Gene Therapy Project for Biology 111. 3dB. Wed Pm. Biotechnology Project on Gene Therapy. Rebecca Proctor, Chiquetta Silver, and Shamonia Wright.
Daniel Reda - An Introduction to Biotechnology and Bioinformatics Daniel Reda, co-Chair of the Biotechnology and Bioinformatics track at Singularity University, introduces the key concepts and breakthroughs in biotechnology and bioinformatics. Filmed during the November 2009 Executive Program at Singularity University.
BIOTECH, India, Turning food waste into biogas - Ashden Award winner This video can be downloaded here: BIOTECH won an Ashden Award for Sustainable Energy in 2007. To find out more visit the link above and check out the Ashden Awards Blog BIOTECH has succeeded in tackling the problem of the dumping of food waste in the streets of Kerala through the installation of biogas plants that use the food waste to produce gas for cooking and, in some cases, electricity for lighting; the residue serves as a fertiliser. To date BIOTECH has built and installed an impressive 12000 domestic plants (160 of which also use human waste from latrines to avoid contamination of ground water), 220 institutional plants and 17 municipal plants that use waste from markets to power generators. The disposal of food waste and the production of clean energy are not the only benefits of BIOTECH's scheme. The plants also replace the equivalent of about 3.7 tonnes of LPG and diesel which in turn results in the saving of about 3700 tonnes/year of CO2, with further savings from the reduction in methane production as a result of the uncontrolled decomposition of waste, and from the transport of LPG.
QIAGEN (Biotech Company) Hiring NBC Washington Jobs 4 You This spot appeared on NBC Washington during the Jobs 4 You segment.
Careers in Biotech Panel Discussion On Thursday, February 24, 2011, a panel discussion geared toward Duke graduate students and postdocs on careers in biotechnology took place at Duke University. Biotech career opportunities are found in agricultural biotechnology, biofuels, biomanufacturing, nanobiotechnology, pharmaceuticals, gene therapy, and regenerative medicine. The biotech industry's competitive job environment can translate to high earning potentials and global employment opportunities. The panelists, all former postdocs and PhD students, discussed their career paths, how they made the transition from academia to biotech, and how current grad students and postdocs could make the same leap. PANELISTS: - Dr. Donna Bortner, CEO, TransViragen Inc (PhD, Microbiology & Immunology, Duke) - Dr. Laura Faulconer, Director of Innovation Projects, Center of Innovation for Nanobiotechnology (COIN) (PhD, BME, UNC-Chapel Hill ) - Dr. Shobha Parthasarathi, Technology Development Director, Business and Technology Development Program, North Carolina Biotechnology Center (PhD, Molecular Genetics & Microbiology, Rutgers) - Dr. Nick Trotta, Project Manager, Research and Applied Markets, Advanced Liquid Logic (PhD, Neurobiology, Vanderbilt)
Sepultura - Biotech is Godzilla This is what can be called a thrash anthem
Biotech & Transhumanism Discussed by Tom & Nita Horn - Pt 1 Tom & Nita Horn on The Harvest Show discussing Biotechnology and the possibility that new sciences are the fullfillment of prophecy that will lead to the return of Nephilim
Biotechnology and Drought: Producing More Crop per Drop Dealing directly with drought conditions is the next frontier. New developments in agricultural biotechnology can play a role in helping American farmers produce crops that use water more efficiently, thus reducing the negative consequences of drought. Climatologists, scientists and farmers today see biotechnology as having the potential to help address this challenge.
Sepultura - Biotech Is Godzilla Hollywood Rock 94
Biotechnology Made in Germany (2007, Part V) The film is about German biotech company MediGene from Munich. The film production has been initiated by the German Ministry of Education and Research (BMBF). The film is part of a DVD that can be ordered for free at .
Biotech Financial Solutions Launch Video CONTINUING TO SUPPORT THE NATION'S EMERGING SECTORS As an innovative financier and development facilitator of the ICT sector, MDV is now extending its portfolio into the rapidly emerging biotechnology sector. MDV has established its own independent team of credit and research professionals and a dedicated fund towards advancing this vibrant sector as one of the main engines of growth for the nation's economy. Your independent vision and leadership with full control. Building a company takes enormous effort and determination from the start. It will ultimately be your vision and leadership that will lead your company to success. MDV takes no stake in your company. Instead we offer the following advantages compared to venture capitalists and other financiers: * Clear and transparent exit mechanism ie repayment of financing * Flexible repayment periods * Independent of stock market conditions * Independent of your company valuation * Maximising returns to shareholders, including existing Venture Capital investors Your application process is accelerated due to our highly-efficient procedures. Upon securing your Biotech project, you would want someone to act on it fast. With complete documentation, we will process your application within a short timeframe. Biotech projects are very time-sensitive and work best when implemented within a specific window of opportunity. Due to our in-depth knowledge of the industry and highly-effective procedures, MDV works fast so that you can ...
One Billionth BioTech Acre There is an intricate relationship between man and the land that sustains him. In the last century farmers have joined with technology in an attempt to overcome both the natural and manmade challenges that they face. As the world demand for food, fiber, renewable energy sources, and a clean and healthy environment has grown, plant biotechnology has made significant advances toward filling these needs. For More Information contact: Info@FastFocus.TV
Opportunities for Open Source Biotechnology in Underdeveloped Countries Google Tech Talks August 5, 2008 ABSTRACT Guido D. Nez-Mujica will be presenting on Science, Innovation and entrepreneurship in developing countries, specifically in Venezuela, where he is from. He decided to stay there, instead of going abroad, to do some cheap biotechnology that is useful to people, solves unmet needs and allows us to use our knowledge for more than academic purposes. The conditions there are very different from the conditions in developed countries. In terms of politics, as well as due to logistic and legal issues, some of those differences are drawbacks, while others can be treated as advantages. He believes that open source models could thrive in underdeveloped countries such as Venezuela and create successful examples of private initiative in places where the public sector runs almost everything. The presentation is less of a detailed ***ysis, and more of a personal perspective and account of the experiences in his lab with a current project: A kit for Chagas disease diagnostic, plus an overview of the general situation and the opportunities it offers. Speaker: Guido D. Núñez-Mujica